Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium-Reference-Cited by-同舟云学术

Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium

Published:2007-04-23 Issue:1 Volume:72 Page:121-131
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Ásgeirsdóttir Sigridur A.,Kamps Jan A. A. M.,Bakker Hester I.,Zwiers Peter J.,Heeringa Peter,van der Weide Karen,van Goor Harry,Petersen Arjen H.,Morselt Henriëtte,Moorlag Henk E.,Steenbergen E.,Kallenberg Cees G.,Molema Grietje

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Adrian JE, Kamps JA, Scherphof GL, Meijer DK, van Loenen-Weemaes A, Reker-Smit C, Terpstra P and Poelstra K (2007) A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. BBA Biomembranes, in press.

2. Delivery of pharmacologically active dexamethasone into activated endothelial cells by dexamethasone–anti-E-selectin immunoconjugate

3. Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase

4. How corticosteroids control inflammation: Quintiles Prize Lecture 2005

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fuel-propelled nanomotors for acute kidney injury applications;Pharmaceutical Science Advances;2024-12

2. Recruitment of neutrophils in glomeruli in early mouse sepsis is associated with E-selectin expression and activation of endothelial nuclear factor kappa-light-chain-enhancer of activated B cells and mitogen-activated protein kinase pathways;Journal of Leukocyte Biology;2024-07-02

3. The application strategy of liposomes in organ targeting therapy;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Protein and peptide-based renal targeted drug delivery systems;Journal of Controlled Release;2024-02

5. Nanocarrier-Based Localized and Effective Treatment of Renal Disorders: Currently Employed Targeting Strategies;Nanomedicine;2024-01-31